Deals
Veritas, Elliott Consider $20 Billion-Plus Athenahealth Sale
- Owners are evaluating sale or IPO by first quarter 2022
- Athenahealth’s valuation seen buoyed by demand for health IT
This article is for subscribers only.
Veritas Capital and Elliott Investment Management are exploring options for Athenahealth Inc. including a sale or initial public offering, according to people familiar with the matter.
Veritas and Elliott are aiming for the health information technology company to be valued at more than $20 billion in a transaction, said the people, who asked to not be identified because the matter isn’t public.